UK HLA Typing Market (2025-2030)
The UK HLA Typing Market was valued at $151.07 Million in 2025 and projected to reach to $209.22 Million by 2030, representing a compound annual growth rate of 6.7%. The UK HLA Typing Market is positioned for sustained growth through 2030, driven by increasing transplant volumes, expansion of precision medicine initiatives, and growing investment in genomic diagnostics.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
UK HLA Typing Market Trends and Insights
- The UK market benefits from advanced healthcare infrastructure, increasing transplant procedures, and rising demand for precision diagnostics in immunology.
- The UK's strong regulatory framework and investment in genomic medicine are driving adoption of HLA typing technologies across NHS trusts and private laboratories. In the UK, HLA typing applications span organ transplantation, bone marrow matching, and disease association studies, with transplant centres and diagnostic laboratories as primary end-users.
- The UK market is supported by government initiatives promoting personalized medicine and the expansion of immunohematology services.
- Between 2025 and 2030, the UK is expected to see increased integration of next-generation sequencing (NGS) technologies and automation in HLA testing workflows. The UK's competitive landscape includes both established diagnostic providers and emerging molecular testing companies.
- The market growth is underpinned by rising transplant waiting lists in the UK, improved reimbursement policies, and growing awareness of HLA-related complications in clinical practice..
Key Market Statistics
- CAGR (2025-2030) 6.7% CAGR
- Market Size, 2025 ~USD 151.07 Million
- Forecast, 2030 ~USD 209.22 Million
- Country UK
UK HLA Typing Market Overview
Market Valuation :
The UK HLA Typing Market is valued at £151.07 million in 2025 and is projected to reach £209.22 million by 2030, demonstrating robust growth in the immunodiagnostics sector.
Healthcare Infrastructure :
The UK's advanced NHS infrastructure and investment in genomic medicine drive adoption of HLA typing technologies across transplant centres and diagnostic laboratories nationwide.
Transplant Demand :
Rising organ transplant procedures in the UK, coupled with increased awareness of HLA compatibility testing, fuel demand for accurate and rapid typing solutions.
Regulatory Excellence :
The UK's stringent regulatory framework and MHRA oversight ensure high-quality HLA typing services, supporting market credibility and clinical adoption across healthcare providers.
UK HLA Typing Market Dynamics
- The NHS's commitment to improving transplant outcomes and reducing rejection rates will continue to elevate HLA typing adoption.
- Additionally, advancements in next-generation sequencing technologies and automation in UK diagnostic laboratories will enhance testing efficiency and accessibility.
- Regulatory support for innovative diagnostic solutions and partnerships between academic institutions and commercial providers will further accelerate market expansion, establishing the UK as a leader in immunodiagnostic excellence..
Related Ecosystem
Key Takeaways
- The UK HLA Typing Market is valued at £151.07 million in 2025 and will reach £209.22 million by 2030 at a 6.7% CAGR.
- The UK market is driven by increasing organ transplant demand, NHS modernization, and adoption of NGS-based HLA typing technologies.
- The UK's regulatory environment and investment in genomic medicine support market expansion across public and private diagnostic sectors.
- Rising HLA-related complication awareness and improved reimbursement policies are key growth catalysts in the UK market through 2030.
HLA Typing Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | COMMERCIAL SERVICE PROVIDERS (End User) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 6% from 2025 to 2030 |
| Largest Segment | DIAGNOSTIC APPLICATIONS (Application) |
| Market Size Base Year (Billions) | ~USD 1.72 (2025) |
| Revenue Forecast (Billions) | ~USD 2.3 (2030) |
| Segments Covered | Product & Service, Technology, Type, Application, End User, Diagnostic Application |
UK HLA Typing Market Report Segmentation
6 segment dimensions are covered across the global market.
By Product & Service
- Instruments
- Reagents & Consumables
- Software & Services
By Technology
- Molecular Assay Technologies
- Non-Molecular Assay Technologies
By Type
- Cancer Diagnosis & Prevention
- Donor-Recipient Cross-Matching
- Infectious Disease Testing
- Next-Generation Sequencing
- Other Diagnostic Applications
- Other Pcr-Based Molecular Assays
- Other Sequencing-Based Molecular Assays
- Pcr-Based Molecular Assays
- Real-Time Pcr
- Sanger Sequencing
- Sequence-Specific Oligonucleotide-Pcr
- Sequence-Specific Primar-Pcr
- Sequence-Specific Primer-Pcr
- Sequencing-Based Molecular Assays
- Transfusion Therapy
By Application
- Diagnostic Applications
- Research Applications
By End User
- Commercial Service Providers
- Hospitals & Transplant Centers
- Research Laboratories & Academic Institutes
By Diagnostic Application
- Cancer Diagnosis & Prevention
- Donor-Recipient Cross-Matching
- Infectious Disease Testing
- Other Diagnostic Applications
- Transfusion Therapy
Target Audience
- Diagnostic Laboratory Operators : UK-based and international diagnostic labs need market data to assess demand for HLA typing services, benchmark operational efficiency, and plan capacity investments across NHS and private sectors.
- Medical Device & IVD Manufacturers : Manufacturers of HLA typing reagents, instruments, and software require UK-specific market intelligence to guide product launches, regulatory submissions, and commercial strategies in this growing segment.
- Transplant Centres & Hospital Networks : UK transplant programmes and hospital trusts need insights into testing volumes, technology trends, and best practices to optimise HLA typing workflows and improve patient outcomes.
- Healthcare Consultants & Advisors : Strategy consultants and healthcare advisors serving UK clients require detailed market analysis to support business case development, investment decisions, and operational improvement initiatives.
- Investors & Private Equity Firms : Investment professionals evaluating opportunities in UK healthcare diagnostics need comprehensive market sizing, growth drivers, and competitive dynamics to inform funding and acquisition decisions.
Key Companies in the UK HLA Typing Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| BGI GENOMICS | China | Public Company | Sequencing-based HLA services (NGS, immune repertoire, WES/WGS-derived typing),Reagents & consumables for HLA workflows,Instruments (sequencers and related hardware used for HLA), |
| BECTON DICKINSON AND CO | United States | Public Company | Instruments,Reagents,Software, |
| BD | United States | Public Company | Instruments,Reagents,Software, |
| THERMO FISHER SCIENTIFIC INC. | United States | Public Company | Sequencing-based HLA (NGS, Sanger),PCR-based HLA (SSO, SSP, Real-time),Software and Informatics, |
| ILLUMINA, INC. | United States | Public Company | Sequencing Instruments (NGS platforms used for HLA typing),Sequencing Reagents, Flow Cells, and Library Prep for HLA,Software and DRAGEN-based Secondary Analysis for HLA, |
| QIAGEN | Netherlands | Public Company | Reagents & Consumables (PCR, NGS, sample technologies for HLA workflows),Instruments (PCR, NGS-related, automation, QC),Software & Bioinformatics (HLA analysis, SaaS, interpretation), |
| BIO-RAD LABORATORIES, INC. | United States | Public Company | Reagents & Consumables (PCR and sequencing HLA kits),Instruments (PCR, sequencing-adjacent, and automation),Software & Informatics (HLA analysis, LIS connectivity), |
| F. HOFFMANN-LA ROCHE LTD | United States | ||
| CAREDX, INC. | United States | Public Company | HLA Typing Reagents & Assays (PCR SSO/SSP, Real-time, NGS, Sanger),Instruments & NGS Workflow Components,Software (Ottr, HLA Data Systems, XynQAPI, MedActionPlan, others), |
| DIASORIN S.P.A. | Italy | Public Company | Instruments,Reagents,Software, |
| EUROBIO SCIENTIFIC | France | Public Company | Reagents (PCR and NGS HLA typing),Software (HLA typing analysis and reporting),Instruments (sequencers, ancillary lab systems), |
BGI GENOMICS
BGI Genomics is a Chinese public company founded in 1999 that employs 3,580 people. The company operates in the genomics and genetic sequencing sector.
BECTON DICKINSON AND CO
Becton Dickinson and Co is a United States-based public company founded in 1897 with 72,000 employees. The company operates in the medical devices and diagnostics sector.
BD
BD is a United States-based public company founded in 1897 with 72,000 employees. The company operates in the medical devices and diagnostics sector.
THERMO FISHER SCIENTIFIC INC.
Thermo Fisher Scientific Inc. is a United States-based public company founded in 1956 with 125,000 employees. The company operates in the life sciences and diagnostics industry.
ILLUMINA, INC.
Illumina, Inc. is a United States-based public company founded in 1998 with 8,625 employees. The company specializes in DNA sequencing and genetic analysis technologies.
QIAGEN
QIAGEN is a Netherlands-based public company founded in 1984 with 5,500 employees. The company operates in the molecular diagnostics and life sciences sector.
BIO-RAD LABORATORIES, INC.
Bio-Rad Laboratories, Inc. is a United States-based public company founded in 1952 with 7,450 employees. The company manufactures and distributes life science research and clinical diagnostics products.
F. HOFFMANN-LA ROCHE LTD
Insufficient data available to provide a business description for this company.
CAREDX, INC.
CareDx, Inc. is a United States-based public company founded in 1998 with 763 employees. The company operates in the molecular diagnostics and transplant monitoring sector.
DIASORIN S.P.A.
DiaSorin S.p.A. is an Italy-based public company founded in 1968 with 3,242 employees. The company specializes in diagnostic solutions and immunoassay products.
EUROBIO SCIENTIFIC
Eurobio Scientific is a France-based public company founded in 1997 with 343 employees. The company operates in the life sciences and diagnostics industry.
Reasons to Buy this Report
- Market Size & Growth Trajectory : Access precise valuation data for the UK HLA typing market with 6.7% CAGR through 2030, enabling accurate financial forecasting and investment planning for UK-focused stakeholders.
- NHS & Healthcare Provider Insights : Understand adoption patterns across UK transplant centres, diagnostic labs, and NHS trusts to identify opportunities for service expansion and technology integration within the UK healthcare system.
- Competitive Landscape Analysis : Gain intelligence on UK-based and international competitors operating in the HLA typing space, including market positioning, regulatory compliance, and clinical partnerships.
- Regulatory & Compliance Framework : Navigate the UK's MHRA requirements and quality standards for HLA typing services with detailed insights into regulatory pathways and best practices for market entry and expansion.
- Strategic Growth Opportunities : Identify high-potential segments within UK transplantation, autoimmune diagnostics, and precision medicine to guide product development, partnerships, and market penetration strategies.
Frequently asked questions
What is the current size of the UK HLA Typing Market?
The UK HLA Typing Market is valued at £151.07 million in 2025 and is expected to grow to £209.22 million by 2030.
What is the growth rate of the UK HLA Typing Market?
The UK HLA Typing Market is projected to grow at a compound annual growth rate (CAGR) of 6.7% from 2025 to 2030.
What are the primary applications of HLA typing in the UK?
In the UK, HLA typing is primarily used for organ and bone marrow transplant matching, disease association studies, and immunological diagnostics in NHS and private laboratories.
Which technologies are driving growth in the UK HLA Typing Market?
Next-generation sequencing (NGS), automated testing platforms, and molecular-based HLA typing methods are the key technologies driving market growth in the UK.
Who are the main end-users of HLA typing services in the UK?
The primary end-users in the UK include NHS transplant centres, diagnostic laboratories, blood banks, and private immunohematology facilities.
RESEARCH METHODOLOGY
This research study extensively utilized secondary sources, directories, and databases to identify and gather valuable information for analyzing the global HLA typing market. Additionally, in-depth interviews were conducted with primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives from leading market players, and industry consultants. These interviews helped obtain and validate critical qualitative and quantitative data while assessing the growth prospects. The global market size, initially estimated through secondary research, was then refined and finalized through triangulation with insights from primary research.
Secondary Research
The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the HLA typing market. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various sources from the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various companies and organizations in the HLA typing market. The primary sources from the demand side include OEMs, private and contract testing organizations, and service providers, among others. Primary research was conducted to validate the market segmentation, identify key players, and gather insights on key industry trends & key market dynamics.
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The bottom-up approach was used to estimate and validate the total size of the HLA typing market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- A list of the major global players operating in the HLA typing market was generated.
- Mapping annual revenues generated by major global players from the HLA typing segment (or nearest reported business unit/service category)
- Revenue mapping of key players to cover a major share of the global market as of 2024
- Extrapolating the global value of the HLA Typing industry
Global HLA Typing Market Size: Bottom-up Approach and Top-down Approach
Data Triangulation
After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
HLA typing is a genetic procedure to determine donor-recipient compatibility, cancer & autoimmune disorder diagnosis, pathogen testing, and transfusion therapy. Additionally, it is used in drug testing, disputed paternity, and anthropological studies. Advanced genomic techniques, such as PCR and NGS, are increasingly being used in HLA typing, apart from serological and other conventional techniques for immuno-compatibility testing.
Stakeholders
- HLA Typing Product Manufacturers
- Healthcare Service Providers (Hospitals, Transplant Centers, and Blood Transfusion Centers)
- Blood, Tissue, and Stem Cell Banks
- Government Organizations
- Independent Associations and Regulatory Authorities
- R&D Companies
- Independent Reference Laboratories
- Diagnostic Laboratories
- Clinical Research Organizations
- Research Laboratories and Academic Institutes
Report Objectives
- To define, describe, and forecast the HLA typing market based on technology, product & service, application, end user, and region
- To provide detailed information regarding the major factors influencing the growth potential of the global HLA typing market (drivers, restraints, opportunities, challenges, and trends)
- To analyze the micro markets with respect to individual growth trends, future prospects, and contributions to the global HLA typing market
- To analyze key growth opportunities in the global HLA typing market for key stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of market segments and/or subsegments with respect to five major regions, namely, North America (the US and Canada), Europe (Germany, the UK, France, Italy, Spain, and Rest of Europe), Asia Pacific (Japan, China, India, Australia, South Korea, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and the Middle East & Africa (GCC Countries and Rest of Middle East & Africa)
- To profile the key players in the HLA typing market and comprehensively analyze their market shares and core competencies
- To track and analyze the competitive developments undertaken in the global HLA typing market, such as agreements, expansions, and acquisitions
Get the Full HLA Typing Market Report
Full forecast, segment splits, and company analysis for all HLA Typing Market.
- Canada HLA Typing Market
- US HLA Typing Market
- Germany HLA Typing Market
- France HLA Typing Market
- Spain HLA Typing Market
- Italy HLA Typing Market
- China HLA Typing Market
- Japan HLA Typing Market
- India HLA Typing Market
- South Korea HLA Typing Market
- Australia HLA Typing Market
- Brazil HLA Typing Market
- Mexico HLA Typing Market
- Rest Of Europe HLA Typing Market
- Rest Of Asia HLA Typing Market
- Rest Of Latin America HLA Typing Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
